I agree Sammie....lots of potential here especially if the major components of the Affordable Health Care Act stay in place. I believe that much of what the company has planned is predicated on an easily billable, pre-emptive, diagnostic procedure like the Vasoscan is supposed to be. I'm wondering though, why investors are still being warned that the company has not supplied sufficient information and that a "warning" in that regard is still in effect. I believe, therefore, that more news is coming and in relatively short order. But, certainly, what doctor wouldn't want this device as a diagnostic in their practice both from a patient health and monetary perspective.